Mei-Lun Wang

Mei-Lun Wang, MD, currently serves as the Senior Vice President of Clinical Development at Sonoma Biotherapeutics since October 2024. Previously, Wang held roles as a Clinical Development Consultant at Ipsen and Vice President of Clinical Development at Alladapt Immunotherapeutics, focusing on pivotal trials and the clinical strategy for novel treatments in food allergies. Prior experience includes serving as Director of Clinical Development at Janssen Inc., where Wang led clinical oversight for trials in Crohn's disease and ulcerative colitis, and Experimental Clinical Development Physician at GSK, overseeing the development of belimumab for pediatric systemic lupus erythematosus. Wang's earlier positions include Assistant Professor of Pediatrics at The Children's Hospital of Philadelphia and Pediatric Gastroenterology Fellow, with a strong foundation in clinical research and pediatric gastroenterology established during a medical education at the University of Pennsylvania School of Medicine and an undergraduate degree from Cornell University.